Bristol-Myers Squibb
BMY
#170
Rank
S$173.11 B
Marketcap
S$84.75
Share price
-0.55%
Change (1 day)
39.26%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): S$4.57

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is S$4.53. In 2025 the company made an earnings per share (EPS) of S$4.40 an increase over its 2024 EPS that were of S-$5.63.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$4.573.76%
2025S$4.40-178.28%
2024S-$5.63-213.92%
2023S$4.9430.2%
2022S$3.79-6.04%
2021S$4.04-179.29%
2020S-$5.09-281.37%
2019S$2.81-27.21%
2018S$3.86
2016S$3.40175.26%
2015S$1.23-19.83%
2014S$1.54-22.44%
2013S$1.9934.48%
2012S$1.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.12 145.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$8.94 97.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$1.67-63.20%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$2.62-42.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$35.93 692.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.43 306.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$3.26-28.10%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$11.90 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$4.55 0.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$8.85 95.22%๐Ÿ‡ฌ๐Ÿ‡ง UK